Genpact (NYSE:G – Get Free Report) was downgraded by analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a report released on Saturday, Wall Street Zen reports.
Several other research analysts have also issued reports on the stock. JPMorgan Chase & Co. raised their target price on shares of Genpact from $40.00 to $45.00 and gave the company a “neutral” rating in a research note on Friday, August 7th. Needham & Company LLC lifted their price target on shares of Genpact from $45.00 to $55.00 and gave the stock a “buy” rating in a research report on Friday. Susquehanna boosted their price target on shares of Genpact from $40.00 to $42.00 and gave the stock a “neutral” rating in a research note on Friday. Weiss Ratings upgraded shares of Genpact from a “hold (c-)” rating to a “hold (c)” rating in a report on Wednesday, October 14th. Finally, Citigroup increased their price objective on shares of Genpact from $32.00 to $36.00 and gave the company a “neutral” rating in a report on Friday, August 7th. Two investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $41.00.
View Our Latest Stock Report on G
Genpact Price Performance
Genpact stock opened at $42.24 on Friday. The business’s 50-day simple moving average is $36.53 and its 200 day simple moving average is $35.53. The stock has a market cap of $7.06 billion, a price-to-earnings ratio of 12.32, a P/E/G ratio of 1.12 and a beta of 0.53. Genpact has a 12-month low of $26.85 and a 12-month high of $48.64. The company has a quick ratio of 2.00, a current ratio of 1.95 and a debt-to-equity ratio of 0.42.
Genpact (NYSE:G – Get Free Report) last announced its quarterly earnings data on Thursday, November 5th. The business services provider reported $1.07 EPS for the quarter, topping analysts’ consensus estimates of $1.04 by $0.03. The firm had revenue of $1.39 billion during the quarter, compared to analyst estimates of $1.38 billion. Genpact had a return on equity of 23.02% and a net margin of 11.04%. The company’s revenue was up 7.3% on a year-over-year basis. During the same period last year, the company earned $0.97 earnings per share. As a group, research analysts anticipate that Genpact will post 3.66 earnings per share for the current year.
Insiders Place Their Bets
In other Genpact news, SVP Anil Nanduru sold 6,191 shares of the stock in a transaction dated Wednesday, August 19th. The stock was sold at an average price of $37.03, for a total value of $229,252.73. Following the transaction, the senior vice president owned 70,253 shares of the company’s stock, valued at approximately $2,601,468.59. This represents a 8.10% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders own 1.58% of the company’s stock.
Hedge Funds Weigh In On Genpact
Several institutional investors have recently modified their holdings of G. Pension & Wealth Management Advisors Inc. acquired a new position in Genpact in the third quarter valued at about $27,000. Root Financial Partners LLC bought a new stake in shares of Genpact in the third quarter worth about $30,000. Basecamp Wealth Advisors LLC increased its holdings in shares of Genpact by 54.7% in the first quarter. Basecamp Wealth Advisors LLC now owns 1,046 shares of the business services provider’s stock worth $39,000 after acquiring an additional 370 shares in the last quarter. Elevation Wealth Partners LLC raised its position in shares of Genpact by 57.2% during the third quarter. Elevation Wealth Partners LLC now owns 1,339 shares of the business services provider’s stock worth $44,000 after purchasing an additional 487 shares during the period. Finally, Mirae Asset Global Investments Co. Ltd. acquired a new stake in shares of Genpact during the third quarter worth about $77,000. 96.03% of the stock is currently owned by institutional investors and hedge funds.
Key Stories Impacting Genpact
Here are the key news stories impacting Genpact this week:
- Positive Sentiment: Genpact reported third-quarter adjusted EPS of $1.07, above estimates of about $1.04–$1.05 and up from $0.97 a year earlier. Revenue increased 7.3% year over year, while ATS revenue grew about 30% and gross margin expanded. Management raised its 2026 gross-margin and adjusted-EPS outlook. G Q3 Earnings Beat Estimates on ATS Growth, Margins Expand
- Positive Sentiment: Needham raised its price target from $45 to $55 and maintained a Buy rating, signaling further potential upside in its view. Needham analyst recommendations
- Neutral Sentiment: Susquehanna lifted its target from $40 to $42 but kept a Neutral rating, indicating a more cautious view than Needham’s. Susquehanna analyst recommendations
- Negative Sentiment: Genpact’s fourth-quarter 2026 revenue guidance of $1.2 billion is below the reported consensus estimate of $1.4 billion, a potential concern that could temper the positive reaction to the quarterly results.
Genpact Company Profile
Genpact is a global professional services company that helps businesses improve operations and pursue digital transformation. Its services include business process management, consulting, data and analytics, artificial intelligence, and technology implementation.
The company works with clients across industries such as banking and financial services, insurance, consumer goods, healthcare, life sciences, manufacturing, and technology. It serves organizations around the world through its global operations.
Genpact began in 1997 as a business services operation within GE Capital and became an independent company in 2005.
Further Reading
- Five stocks we like better than Genpact
- Lemonade’s Revenue Soars 73%—So Why Did Its Stock Turn Sour After Earnings?
- Anthropic’s S-1 Strengthens the Case for Broadcom’s AI Growth
- After the Midterms, Which of These 3 Defense ETFs Looks Strongest?
- The Ugly Truth Behind SoundHound’s Q3 Results
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.
